Beone Medicines Ltd. Class A · SSE:688235
Oyler John sold 240,810 Beone Medicines Ltd. Class A shares (Form 4)
Traded Aug 10 to Aug 12, 2026 · Filed Aug 12, 2026
From Aug 10 to Aug 12, 2026, Oyler John (Director, Chief Executive Officer) sold 240,810 Beone Medicines Ltd. Class A shares at an average US$359.12 for US$86.5M under a trading plan, leaving 0 shares. Filed Aug 12, 2026 (Form 4).
- Sold
- 240,810 shares
- Price
- US$359.12 average (US$350.00 to US$367.00)
- Value
- US$86.5M
- Holding after
- 0 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | American Depositary Shares | Sale | 67 | US$350.00 | 240,743 | Direct |
| Aug 10, 2026 | American Depositary Shares | Sale | 2,813 | US$351.80 | 237,930 | Direct |
| Aug 10, 2026 | American Depositary Shares | Sale | 3,673 | US$353.32 | 234,257 | Direct |
| Aug 10, 2026 | American Depositary Shares | Sale | 6,717 | US$354.78 | 227,540 | Direct |
| Aug 10, 2026 | American Depositary Shares | Sale | 3,476 | US$355.66 | 224,064 | Direct |
| Aug 10, 2026 | American Depositary Shares | Sale | 12,418 | US$356.62 | 211,646 | Direct |
| Aug 10, 2026 | American Depositary Shares | Sale | 15,869 | US$357.67 | 195,777 | Direct |
| Aug 10, 2026 | American Depositary Shares | Sale | 45,044 | US$358.70 | 150,733 | Direct |
| Aug 10, 2026 | American Depositary Shares | Sale | 21,254 | US$359.50 | 129,479 | Direct |
| Aug 10, 2026 | American Depositary Shares | Sale | 3,680 | US$360.63 | 125,799 | Direct |
| Aug 11, 2026 | American Depositary Shares | Sale | 13,695 | US$359.32 | 112,104 | Direct |
| Aug 11, 2026 | American Depositary Shares | Sale | 8,081 | US$360.33 | 104,023 | Direct |
| Aug 11, 2026 | American Depositary Shares | Sale | 14,569 | US$361.47 | 89,454 | Direct |
| Aug 11, 2026 | American Depositary Shares | Sale | 11,568 | US$362.34 | 77,886 | Direct |
| Aug 11, 2026 | American Depositary Shares | Sale | 13,403 | US$363.45 | 64,483 | Direct |
| Aug 11, 2026 | American Depositary Shares | Sale | 5,211 | US$364.31 | 59,272 | Direct |
| Aug 11, 2026 | American Depositary Shares | Sale | 3,176 | US$365.26 | 56,096 | Direct |
| Aug 11, 2026 | American Depositary Shares | Sale | 1,200 | US$366.31 | 54,896 | Direct |
| Aug 11, 2026 | American Depositary Shares | Sale | 4 | US$367.00 | 54,892 | Direct |
| Aug 12, 2026 | American Depositary Shares | Sale | 1,980 | US$354.71 | 52,912 | Direct |
| Aug 12, 2026 | American Depositary Shares | Sale | 2,515 | US$356.43 | 50,397 | Direct |
| Aug 12, 2026 | American Depositary Shares | Sale | 15,396 | US$357.63 | 35,001 | Direct |
| Aug 12, 2026 | American Depositary Shares | Sale | 20,899 | US$358.41 | 14,102 | Direct |
| Aug 12, 2026 | American Depositary Shares | Sale | 14,102 | US$359.12 | 0 | Direct |
Source
Related
- Beone Medicines Ltd. Class A
- Oyler John
- Beone Medicines Ltd. Class A shareholders
- Form 4 · Oyler John · Jul 22, 2026
- Form 4 · Oyler John · Jul 17, 2026
- Form 4 · Oyler John · Jul 17, 2026
- Form 4 · Oyler John · Jul 14, 2026
- Form 4 · Oyler John · Jul 14, 2026
- Form 4 · Wang Xiaodong · Oct 15, 2026
- Form 4 · Lee Chan Henry · Oct 2, 2026
- Form 4 · Wang Xiaodong · Sep 30, 2026
- Form 4 · Baker Bros. Advisors LP · Sep 16, 2026
- Schedule 13D/A · Baker Bros. Advisors LP · Sep 16, 2026